0

Clomiphene citrate in the management of anovulatory uterine bleeding

Puebla RA et al., 1964

The Journal of clinical endocrinology and metabolism, 24(9), 863-866

DOI 10.1210/jcem-24-9-863 PMID 14216475 Source

Abstract

Clomiphene citrate [1-p(β-diethylaminoethoxy) phenyl-1,2-diphenyl-2-chloroethylene citrate], because of its ability to induce ovulation, was administered to 26 patients with excessive anovulatory uterine bleeding. Of the 129 menstrual cycles during which the drug was administered, 105 cycles (81.3%) were ovulatory and were followed by normal uterine bleeding. After clomiphene was discontinued, observations made in 52 cycles showed that only 20 (38.4%) were ovulatory

Topics

Reproductive Endocrinology > Ovulation > InductionMenstrual Cycle > Disorders > OligomenorrheaInfertility > Female Factor > Ovulatory Dysfunction
clomiphene for anovulatory bleeding, clomid menstrual irregularities, ovulation induction abnormal uterine bleeding, anovulatory cycles treatment clomiphene, clomiphene citrate uterine bleeding, dysfunctional bleeding ovulation induction, anovulation bleeding management, clomid cycle regulation

Cite this article

Puebla, R. A., & Greenblatt, R. B. (1964). Clomiphene citrate in the management of anovulatory uterine bleeding. *The Journal of clinical endocrinology and metabolism*, *24*(9), 863-866. https://doi.org/10.1210/jcem-24-9-863

Keywords

Adolescent, Clomiphene, Drug Therapy, Female, Humans, Ovulation, Stilbenes, Uterine Hemorrhage, ADOLESCENCE

Related articles